Skip to content

Faculty profile

Ali Mirazimi

Back to faculty
ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.

Latest funding

  • COVID-19 Variant Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)

    CIHR · 2021 · Principal investigator

    $50,000
  • Sex as a Biological Variable Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)

    CIHR · 2020 · Principal investigator

    $50,000
  • Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)

    CIHR · 2020 · Principal investigator

    $1,000,000
All 3 grants and awards
Something wrong or missing on this profile? Suggest a correction